BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
ZBTB7A
,
nitric oxide metabolic process
,
Ischemia
,
Stem cell
,
Prozac
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TGFα
Summary
General Info
Curated Studies
Most Correlated Studies
Lungs from mice conditionally expressing TGF-alpha to induce pulmonary fibrosis
Lungs of mice with TGF-alpha induced fibrosis, treated with MAPK (ARRY) and PI3K (PX-886) inhibitors
Explore Curated Studies Results
Literature
Most Relevant Literature
Determination of mTOR signal pathway in MMTV-TGFα mice ovary at different ages.
Stimulatory effects of TGFα in granulosa cells of bovine small antral follicles.
TGFα preserves oligodendrocyte lineage cells and improves white matter integrity after cerebral isch…
Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma.
MicroRNA-183 attenuates osteoarthritic pain by inhibiting the TGFα-mediated CCL2/CCR2 signalling axi…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for…
Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients
Endometrial Markers in Autoimmune Diseases
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Wound Vitality Markers in Forensic Pathology
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ